_
Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:

PO Box 322,
Modbury,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (PDF, 156KB)
Why become a member?

The Cortene ME/CFS Drug Trial Begins

Thursday 16 August 2018

 

From Health Rising:

 

Decisions
Cortene used a theoretical exercise to rethink how
ME/CFS occurs to help them determine
if their drug might be a good fit.
 

The Cortene Chronic Fatigue Syndrome (ME/CFS) Drug Trial Begins

By Cort Johnson
July 14, 2018

Since February, Health Rising has described the development of a new drug produced for chronic fatigue syndrome (ME/CFS) by a small pharmaceutical company named Cortene in three blogs:

Now it’s time to test the drug! Cortene’s trial has received the go-ahead from both the FDA and the Independent Review Board (IRB) and the trial will commence shortly, with Lucinda Bateman, MD, as the Principal Investigator, Suzanne Vernon, PhD, as Co-Investigator, and assisted by the experienced clinical trials team at the Bateman Horne Center.

 

Full article…

 


 

blog comments powered by Disqus
Previous Previous Page